Table 4.
Raw means ± SD of ECG analysis parameters in healthy controls and dialysis patients
| Controls (N = 15) | Diabetic HD (N = 14) | Nondiabetic HD (N = 14) | All HD (N = 28) | |
|---|---|---|---|---|
| Heart rate (/min) | 69.0 [12.0] | 78.0 [14.0]* | 78.5 [28.3] | 78.5 [19.5] |
| SDNN (ms) | 34.0 [14.0] | 13.0 [14.0]** | 18.0 [15.3]** | 15.5 [14.8] |
| pNN50 (%) | 3.0 [8.0] | 0.5 [1.3] | 0.0 [1.3]* | 0.0 [1.0] |
| VLF (s2 x10−3) | 0.72 [0.87] | 0.12 [0.21]** | 0.20 [0.35]** | 0.12 [0.29] |
| LF (s2 x10−3) | 0.39 [0.29] | 0.035 [0.21]** | 0.076 [0.20]** | 0.052 [0.18] |
| HF (s2 x10−3) | 0.27 [0.22] | 0.08 [0.1]** | 0.06 [0.11]** | 0.07 [0.09] |
| LF/HF | 1.1 [1.3] | 0.8 [1.0] | 0.7 [2.2] | 0.8 [1.2] |
* = p < 0.05 vs. controls; ** = p < 0.01 vs. controls; *** = p < 0.001 vs. controls; by nonparametric Kruskal-Wallis and Dunn’s test. Statistical tests were done for the three groups controls, diabetic and nondiabetic patients. The column “all HD” remained untested